Efficacy and safety of flupentixol and melitracen tablets adjuvant therapy in the treatment of refractory non-erosive gastroesophageal reflux disease

WANG Guangxin; FENG Yikuan

doi:10.7619/jcmp.201811010

WANG Guangxin, FENG Yikuan. Efficacy and safety of flupentixol and melitracen tablets adjuvant therapy in the treatment of refractory non-erosive gastroesophageal reflux disease[J]. Journal of Clinical Medicine in Practice, 2018, (11): 36-40. DOI: 10.7619/jcmp.201811010

Citation:

WANG Guangxin, FENG Yikuan. Efficacy and safety of flupentixol and melitracen tablets adjuvant therapy in the treatment of refractory non-erosive gastroesophageal reflux disease[J]. Journal of Clinical Medicine in Practice, 2018, (11): 36-40. DOI: 10.7619/jcmp.201811010

Citation:

WANG Guangxin, FENG Yikuan. Efficacy and safety of flupentixol and melitracen tablets adjuvant therapy in the treatment of refractory non-erosive gastroesophageal reflux disease[J]. Journal of Clinical Medicine in Practice, 2018, (11): 36-40. DOI: 10.7619/jcmp.201811010

Efficacy and safety of flupentixol and melitracen tablets adjuvant therapy in the treatment of refractory non-erosive gastroesophageal reflux disease

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Efficacy and safety of flupentixol and melitracen tablets adjuvant therapy in the treatment of refractory non-erosive gastroesophageal reflux disease

Graphical Abstract

Catalog

Export File

Citation

Format

Content